Advertisement

Daily Report from the ACR Annual Meeting

The 2017 annual meeting of the American College of Rheumatology (ACR) and the Association of Rheumatology Health Professionals (ARHP) was hosted November 3–8, 2017, in San Diego, CA. The event provided more than 450 educational opportunities regarding rheumatology research and clinical applications, presented by leading rheumatology experts. Each day, AMCP covered highlights from the meeting, which can be accessed via the quick links to the left.

Secukinumab Provides Rapid and Sustained Pain Relief in Ankylosing Spondylitis, as Well as Improvements...

Secukinumab, a fully human monoclonal antibody that selectively neutralizes IL-17A, has shown sustained efficacy in patients with active ankylosing spondylitis (AS), a form of arthritis that causes inflammation of the spinal joints (vertebrae) that can lead to severe, chronic pain and discomfort.

Patients with Psoriatic Arthritis Achieve Remission and Minimal Disease Activity with Secukinumab

For patients with psoriatic arthritis (PsA), a chronic disease characterized by a form of inflammation of the skin and joints, the optimal aim of treatment is very low disease activity (VLDA) or remission. Minimal disease activity (MDA) and low disease activity (LDA) are also good results of treatment.

Study Examines Factors That Influence Adherence to Lupus Therapy

New research presented at the 2017 annual meeting of the American College of Rheumatology (ACR) and the Association of Rheumatology Health Professionals (ARHP) shows that Medicare beneficiaries with lupus who live in areas with higher proportions of African Americans, fewer hospitals and less access to health professionals have lower adherence to their lupus therapy.

Shock-Wave Therapy Successfully Treats Finger Ulcers in Scleroderma Patients

Systemic sclerosis, otherwise known as scleroderma, is a rare but serious autoimmune disease that hardens and tightens the skin and connective tissue. It is associated with severe complications, including kidney disease, pulmonary arterial hypertension, lung inflammation or gastrointestinal problems.

Spine Osteoarthritis Patients & Those Under 65 More Likely to Use Opioids to Manage...

A large percentage of patients with end-stage osteoarthritis use opioids to manage their chronic pain, particularly younger patients and those who have symptoms of depression, according to a research team presenting study results at the 2017 annual meeting of the American College of Rheumatology (ACR) and the Association of Rheumatology Health Professionals (ARHP).
Advertisement